CSL Behring Germany today announced that the first haemophilia B patient in Germany was treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at the Hemophilia Treatment Center at ...

The first haemophilia B patient in Germany has been treated with the one-time gene therapy HEMGENIX at the Hemophilia Treatment Center at Hannover Medical School, CSL Behring Germany has announced.

Discover why options trading trends, robust R&D, and strong free cash flow position Pfizer Inc. for growth. Click for my ...

Fatigue during your period could also simply be due to the normal hormone changes that occur throughout a cycle, Dr. Culwell ...

Pfizer’s anti-TFPI antibody marstacimab has been approved by the FDA to treat haemophilia, becoming the pharma group’s second new therapy for the blood disorder this year. Marstacimab will be ...

Last year's estimates suggest that as many as 1.1 million eligible people are missing out on Attendance Allowance support.

Columnist Joe MacDonald describes his early adjustments to cope with the reality of his oldest son's hemophilia.

The Government of Kerala oversees the Kerala State Lotteries program. It was founded in 1967 and is the first of its kind in ...

Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector. TaxStatus is the only firm to provide the comprehensive information advisors need to ...

If you have a long-term illness or disability and you’ve reached State Pension age, you may be entitled to a benefit called ...

Eligible Brits typically need to have a condition 'severe enough' to require care or supervision from another person ...